Scott Sandell Net Worth & Insider Trades

Scott Sandell Regulus Therapeutics Inc

As of March 16, 2021

What is Scott Sandell's Net Worth?

The current estimated net worth of Regulus Therapeutics Inc's Scott Sandell is estimated to be about $2B . Scott Sandell owns about 6,451,056 units of Regulus Therapeutics Inc common stock. In the last 2 years at Regulus Therapeutics Inc, Scott Sandell has sold an estimated value of $0 worth.

What is Scott Sandell's Past Insider Trading?

Scott Sandell's largest purchase order was 4,398,602 units , worth over $2.74M on December 7, 2020. In total, Scott Sandell has made about 4 transactions over 2 years of their time at Regulus Therapeutics Inc. Scott Sandell usually trades in December, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Regulus Therapeutics Inc's Past Insider Trades?

Regulus Therapeutics Inc's most recent insider trade came on March 1, 2022 by Denis Drygin who bought 76,686 units worth $17.64K . In the last 10 years, insiders at Regulus Therapeutics Inc have sold an estimated value of $79.77M and bought an estimated value of $68.69M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Joseph Hagan, President and CEO,  Stelios Papadopoulos, Director,  and Christopher Aker, Sr. VP & General Counsel .

Regulus Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1